加利福尼亚州桑尼维尔，2026年9月23日/美通社/——GRAIL公司是一家以在癌症尚可治愈的早期阶段实现精准检测为使命的医疗健康企业。该公司今日宣布，美国食品药品监督管理局（FDA）医疗器械咨询委员会分子与临床遗传学器械小组已对Galleri多癌种早期检测（MCED）产品的上市前批准（PMA）申请作出有利投票。在三 ...

Thelatest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and ...

St. Luke’s Cancer Institute’s new linear accelerator delivers precise radiation treatment while helping protect healthy ...

Scientists have found solutions to two major problems associated with the treatment of cancer: recurrence and damage to ...

A machine learning study of 351 breast cancer patients shows that MRI radiomics features from both the tumor and its ...

Interventional oncology has evolved from image-guided biopsies into a fourth pillar of cancer care, combining ablation, ...

A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.

Professor Chris Elliot OBE, a former government food safety advisor, says clamping down on nitrates and nitrites could slash ...

The National Health Insurance Authority has expanded insurance support to cut cancer treatment costs, shielding eligible ...

Patients don’t feel the radiation as it’s delivered, and many treatments are provided in an outpatient setting.

A cancer treatment has reached a remarkable milestone. While Chimeric Antigen Receptor (CAR) T-cell therapy has shown promising effects on blood cancers, like particular types of leukemia or lymphoma, ...